Ruxolitinib for disease-related splenomegaly or symptoms in adults with myelofibrosis (review of TA289)

Robert Hodgson, Ros Wade, Mousumi Biswas, Melissa Harden, Nerys Frances Woolacott*

*Corresponding author for this work

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherNational Institute for Health and Care Excellence
Commissioning bodyNational Institute for Health and Care Excellence
Publication statusPublished - 23 Mar 2016

Cite this